Bavarian Nordic Discloses Share Buyback Activity Under DKK 250M Program
Bavarian Nordic is repurchasing shares worth up to DKK 250 million between Sept. 1 and Oct. 30, 2026, under EU market-abuse safe-harbor rules.
Bavarian Nordic A/S, the Copenhagen-listed vaccine maker trading on the Nasdaq Copenhagen exchange under the ticker BAVA, disclosed transactions this week tied to a share repurchase program it launched September 1, 2026. The company has authorized buybacks totaling up to DKK 250 million over a two-month window that closes October 30, 2026.
The program operates under the European Union's market-abuse framework, specifically Regulation (EU) No. 596/2014 and Commission Delegated Regulation (EU) 2016/1052. Together those rules establish a so-called Safe Harbour Regulation, which sets conditions under which companies may repurchase their own shares without running afoul of insider-trading or market-manipulation prohibitions.
Read more SWFI Plans $5 Trillion US Investment Summit in Miami for 2026 →
Share buyback programs of this type are a common mechanism for publicly traded European companies to return capital to shareholders while maintaining compliance with regional securities law. By repurchasing stock on the open market under the safe-harbor framework, issuers must adhere to strict limits on volume, price, and timing to preserve transparency and market integrity.
Bavarian Nordic has not disclosed in this announcement the specific number of shares acquired, the average price paid, or the cumulative total repurchased to date under the program. Further transaction detail is typically reported to regulators and made public on a weekly basis in accordance with EU disclosure requirements.
Continue reading at GlobeNewswire - Industry News on Financial Services.
